2012.This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Reviewed Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (available,August -
KellyJA,MurphyDA,SikkemaKJ,McAuliffeTL,RoffmanRA,SolomonLJ,WinettRA,KalichmanSC,CollaborativeTC, 1997.Randomised, controlled, communitylevel HIV-prevention intervention for sexualrisk behaviour among homosexual men in US cities,Lancet 350 1500 -5
ParkBJ,WannemuehlerKA,MarstonBJ,GovenderN,PappasPG,ChillerTM, 2009.Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS, 23 525 -30
WenigerBG,LimpakarnjanaratK,UngchusakK,ThanprasertsukS,ChoopanyaK,VanichseniS,UneklabhT,ThongcharoenP,WasiC., 1991.From the National Institute of Allergy and Infectious Diseases (NIAID): Understanding HIV/AIDS., 5 71 -86
HealthR,ServicesA, 2003.Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR. Recommendations and reports: Morbidity and mortality weekly report,Recommendations and reports/ Centers for Disease Control 18 1 -
CoatesTJ, 2000.Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial,Lancet 356 103 -12
FarmerP,LéandreF,MukherjeeJS,ClaudeM,NevilP,Smith-FawziMC,KoenigSP,CastroA,BecerraMC,SachsJ,AttaranA, 2001.Community-based approaches to HIV treatment in resource-poor settings,Lancet 358 404 -9
PerrinL,TelentiA, 1998.HIV treatment failure: testing for HIV resistance in clinical practice,Science 280 1871 -3
FriedlandGH,WilliamsA, 1999.Attaining higher goals in HIV treatment: the central importance of adherence,AIDS (London, England) 13 S61 -72
2003.Centers for Disease Control and Prevention (CDC). Advancing HIV prevention: new strategies for a changing epidemic-,Morbidity and Mortality Weekly Report 52 329 -